ResearcherKunming Medical UniversityActive in the last 2 years
Desheng Wang
Matched on ORCID iD 0000-0002-5844-0813; OpenAlex author ID A5100733743. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 5
- Identification of mitochondrial-related subtypes and development of a prognostic model for pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/jgo-2025-613↗
- Anti-pancreatic cancer activity of cassane diterpenoids isolated from the seeds of Caesalpinia sappan mediated by autophagy activation via ROS/AMPK/mTORC1 path… First author DOI 10.1016/j.phytochem.2024.114105↗
- Stent Selection in Preoperative Biliary Drainage for Patients With Operable Pancreatic Cancer Receiving Neoadjuvant Therapy: A Meta-Analysis and Systematic Rev… Last author DOI 10.3389/fsurg.2022.875504↗
- Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.tranon.2018.03.005↗
- MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1. Co-author DOI 10.3892/or.2014.3374↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fen Zhang · 1 shared paper, 2026 · strength 0.39
- Shuqiang Yue · 1 shared paper, 2026 · strength 0.39
- Jianbing Du · 1 shared paper, 2022 · strength 0.19
- Lin‐Fen Ding · 1 shared paper, 2024 · strength 0.18
- Jia Su · 1 shared paper, 2024 · strength 0.18
- Xing‐De Wu · 1 shared paper, 2024 · strength 0.18
- Yang Song · 1 shared paper, 2018 · strength 0.08
- Qing Wang · 1 shared paper, 2018 · strength 0.08
- Haichuan Su · 1 shared paper, 2018 · strength 0.08
- Kaishan Tao · 1 shared paper, 2014 · strength 0.05
- Dou Ke-feng · 1 shared paper, 2014 · strength 0.05
- Liang Zhou · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.